August 11, 2025Journal of Cancer BiologyOpen Access

Cancer stem cells as a biomarker – A mini review

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Mini review highlights cancer stem cells’ role in prognosis and resistance to chemotherapy and radiation.

High levels of cancer stem cells often lead to poor prognosis and resistance to conventional therapies, complicating treatment.
Specific markers like CD44 and CD133 can distinguish cancer stem cells from non-stem tumor cells, aiding in targeted therapies.
Understanding the mechanisms of cancer stem cells is crucial for developing effective and personalized cancer treatment options.
Research into cancer stem cell biomarkers is ongoing, aiming to improve diagnosis, prognosis, and treatment across various cancers.

Joshi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark